Recent studies on neural tube defects in embryos of diabetic pregnancy: An overview

Current Medicinal Chemistry

Volumn 16, Issue 18, 2009, Pages 2345-2354

  Dheen, S Thameem ^a   Tay, Samuel S W ^a   Boran, Jiang ^a   Ting, Loh Wan ^a   Kumar, S Dinesh ^a   Fu, Jiang ^a   Ling, Eng Ang ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Development; Gene; Maternal diabetes; Neural tube defects; Proliferation

Indexed keywords

ALDEHYDE REDUCTASE; ARACHIDONIC ACID; BONE MORPHOGENETIC PROTEIN 4; DOUBLECORTIN; FATTY ACID BINDING PROTEIN; FIDARESTAT; FOLIC ACID; GLUCOSE TRANSPORTER; INOSITOL; PENTOSE PHOSPHATE; PREALBUMIN; PROTEIN BID; PROTEIN BNIP3; PROTEIN P53; SONIC HEDGEHOG PROTEIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX2.1; TRANSCRIPTION FACTOR PAX3; UNCLASSIFIED DRUG;

ANENCEPHALUS; APOPTOSIS; BRAIN DEVELOPMENT; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL MIGRATION; CEREBROSPINAL FLUID; CHOROID PLEXUS; DISEASE ASSOCIATION; DOWN REGULATION; DRUG MECHANISM; DRUG STRUCTURE; EMBRYO DEVELOPMENT; EMBRYOPATHY; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; GENE MUTATION; HOLOPROSENCEPHALY; HUMAN; MATERNAL DIABETES MELLITUS; MICROARRAY ANALYSIS; MORPHOGENESIS; NEURAL STEM CELL; NEURAL TUBE DEFECT; NONHUMAN; NOTOCHORD; OXIDATIVE STRESS; PREGNANCY; PROTEIN EXPRESSION; RACE DIFFERENCE; REVIEW; SIGNAL TRANSDUCTION; SYNTELENCEPHALY; TELENCEPHALON; ANIMAL; BRAIN; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEURAL TUBE; PATHOLOGY; PREGNANCY DIABETES MELLITUS; PRENATAL DEVELOPMENT;

ANIMALS; APOPTOSIS; BRAIN; DIABETES, GESTATIONAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; NEURAL TUBE; NEURAL TUBE DEFECTS; OXIDATIVE STRESS; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 67949088293     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709788453069     Document Type: Review

References (133)

1. Rosano, A.; Botto, L. D.; Botting, B.; Mastroiacovo, P. Infant mortality and congenital anomalies from 1950 to 1994: An international perspective. J. Epidemiol. Commun. Health, 2000, 54, 660-666.
2. Kocak, G.; Onal, C.; Kocak, A.; Karakurt, C.; Ates, O.; Cayli, S.R.; Yologlu, S. Prevalence and outcome of congenital heart disease in patients with neural tube defect. J. Child Neurol., 2008, 23, 526-530.
3. Mills, J. L. Malformations in infants of diabetic mothers. Teratology, 1982, 25, 385-394.
4. Sakamaki, H.; Akazawa, S.; Ishibashi, M.; Izumino, K.; Takino, H.; Yamasaki, H.; Yamaguchi, Y.; Goto, S.; Urata, Y.; Kondo, T.; Nagataki, S. Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes, 1999, 48, 1138-1144.
5. Hanson, U.; Persson, B.; Thunell, S. Relationship between haemoglobin A1C in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia, 1990, 33, 100-104.
6. Miller, E.; Hare, J. W.; Cloherty, J. P.; Dunn, P. J.; Gleason, R. E.; Soeldner, J. S.; Kitzmiller, J. L. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N. Engl. J. Med., 1981, 304, 1331-1334
7. Mills, J. L.; Baker, L.; Goldman, A. S. Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes, 1979, 28, 292-293.
8. Becerra, J. E.; Khoury, M. J.; Cordero, J. F.; Erickson, J. D. Diabetes mellitus during pregnancy and the risks for specific birth defects: A population-based case-control study. Pediatrics, 1990, 85, 1-9.
9. Kumar, S. D.; Dheen, S. T.; Tay, S. S. Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development. Cardiovasc. Diabetol., 2007, 6, 34.
10. Kucera, J. Rate and type of congenital anomalies among offspring of diabetic women. J. Reprod. Med., 1971, 7, 73-82
11. Robin, N. H.; Ko, L. M.; Heeger, S.; Muise, K. L.; Judge, N.; Bangert, B. A. Syntelencephaly in an infant of a diabetic mother. Am. J. Med. Genet., 1996, 66, 433-437.
12. Eriksson, U. J. The pathogenesis of congenital malformations in diabetic pregnancy. Diabetes Metab. Rev., 1995, 11, 63-82
13. Ozumba, B. C.; Obi, S. N.; Oli, J. M. Diabetes mellitus in pregnancy in an African population. Int. J. Gynaecol. Obstet., 2004, 84, 114-119.
14. Moum, K. R.; Holzman, G. S.; Harwell, T. S.; Parsons, S. L.; Adams, S. D.; Oser, C. S.; Spence, M. R.; Helgerson, S. D.; Gohdes, D. Increasing rate of diabetes in pregnancy among American Indian and white mothers in Montana and North Dakota, 1989-2000. Matern. Child Health J., 2004, 8, 71-76.
15. Lapolla, A.; Dalfra, M. G.; Lencioni, C.; Di, C. G. Epidemiology of diabetes in pregnancy: A review of Italian data. Diabetes Nutr. Metab., 2004, 17, 358-367.
16. Kieffer, E. C.; Martin, J. A.; Herman, W. H. Impact of maternal nativity on the prevalence of diabetes during pregnancy among U. S. ethnic groups. Diabetes Care, 1999, 22, 729-735.
17. Arteaga, J.; Luna, L.; Mutchinick, O. M. Diabetes, pregnancy and birth defects. Rev. Invest. Clin., 2008, 60, 107-114
18. Mills, J. L.; Withiam, M. J. Diabetes, pregnancy, and malformations: An epidemiologic perspective. In Diabetes and pregnancy: Teratology, toxicity and treatment. (ed. L. Jovanovic, C. M. Peterson, and K. Fuhrmann), Praeger Publishers: New York, 1986, pp 3-14.
19. Aberg, A.; Westbom, L.; Kallen, B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum. Dev., 2001, 61, 85-95.
20. Day, R. E.; Insley, J. Maternal diabetes mellitus and congenital malformation. Survey of 205 cases. Arch. Dis. Child, 1976, 51, 935-938.
21. Farrell, T.; Neale, L.; Cundy, T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet. Med., 2002, 19, 322-326.
22. Ramos-Arroyo, M. A.; Rodriguez-Pinilla, E.; Cordero, J. F. Maternal diabetes: The risk for specific birth defects. Eur. J. Epidemiol., 1992, 8, 503-508.
23. Sharpe, P. B.; Chan, A.; Haan, E. A.; Hiller, J. E. Maternal diabetes and congenital anomalies in South Australia 1986-2000: A population-based cohort study. Birth Defects Res. A Clin. Mol. Teratol., 2005, 73, 605-611.
24. Amankwah, K. S.; Kaufmann, R.; Roller, R. W.; Dawson-Saunders, B.; Prentice, R. L. Incidence of congenital abnormalities in infants of gestational diabetic mothers. J. Perinat. Med., 1981, 9, 223-227.
25. Cowett, R. M.; Schwartz, R. The infant of the diabetic mother. Pediatr. Clin. North Am., 1982, 29, 1213-1231.
26. Gabbe, S. G. Congenital malformations in infants of diabetic mothers. Obstet. Gynecol. Surv., 1977, 32, 125-132.
27. Lee, M. C.; Wang, P. J.; Chen, R. L. Lumbosacral agenesis in a premature infant of a diabetic mother. Acta Paediatr. Taiwan, 2003, 44, 375-378.
28. Singh, S. K.; Singh, R. D.; Sharma, A. Caudal regression syndrome-case report and review of literature. Pediatr. Surg. Int., 2005, 21, 578-581.
29. Comess, L. J.; Bennett, P. H.; Burch, T. A.; Miller, M. Congenital anomalies and diabetes in the Prima Indians of Arizona. Diabetes, 1969, 18, 471-477.
30. Copp, A. J.; Bernfield, M. Etiology and pathogenesis of human neural tube defects: Insights from mouse models. Curr. Opin. Pediatr., 1994, 6, 624-631.
31. Juriloff, D. M.; Harris, M. J. Mouse models for neural tube closure defects. Hum. Mol. Genet., 2000, 9, 993-1000.
32. Liao, D. M.; Ng, Y. K.; Tay, S. S.; Ling, E. A.; Dheen, S. T. Altered gene expression with abnormal patterning of the telencephalon in embryos of diabetic Albino Swiss mice. Diabetologia, 2004, 47, 523-531.
33. Cohen, M. M., Jr.; Sulik, K. K. Perspectives on holoprosencephaly: Part II. Central nervous system, craniofacial anatomy, syndrome commentary, diagnostic approach, and experimental studies. J. Craniofac. Genet. Dev. Biol., 1992, 12, 196-244.
34. Xuan, S.; Baptista, C. A.; Balas, G.; Tao, W.; Soares, V. C.; Lai, E. Winged helix transcription factor BF-1 is essential for the development of the cerebral hemispheres. Neuron, 1995, 14, 1141-1152.
35. Furuta, Y.; Piston, D. W.; Hogan, B. L. Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development. Development, 1997, 124, 2203-2212.
36. Liem, K. F., Jr.; Tremml, G.; Roelink, H.; Jessell, T. M. Dorsal differentiation of neural plate cells induced by BMP-mediated signals from epidermal ectoderm. Cell, 1995, 82, 969-979
37. Fine, E. L.; Horal, M.; Chang, T. I.; Fortin, G.; Loeken, M. R. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes, 1999, 48, 2454-2462.
38. Phelan, S. A.; Ito, M.; Loeken, M. R. Neural tube defects in embryos of diabetic mice: Role of the Pax-3 gene and apoptosis. Diabetes, 1997, 46, 1189-1197.
39. Jiang, B.; Kumar, S. D.; Loh, W. T.; Manikandan, J.; Ling, E. A.; Tay, S. S.; Dheen, S. T. Global gene expression analysis of cranial neural tubes in embryos of diabetic mice. J. Neurosci. Res., 2008, 86, 3481-3493.
40. Dziegielewska, K. M.; Ek, J.; Habgood, M. D.; Saunders, N. R. Development of the choroid plexus. Microsc. Res. Tech., 2001, 52, 5-20.
41. Yamamoto, M.; McCaffery, P.; Drager, U. C. Influence of the choroid plexus on cerebellar development: Analysis of retinoic acid synthesis. Brain Res. Dev. Brain Res., 1996, 93, 182-190.
42. Gato, A.; Moro, J. A.; Alonso, M. I.; Bueno, D.; De La, M. A.; Martin, C. Embryonic cerebrospinal fluid regulates neuroepithelial survival, proliferation, and neurogenesis in chick embryos. Anat. Rec. A Discov. Mol. Cell Evol. Biol., 2005, 284, 475-484.
43. Miyan, J. A.; Nabiyouni, M.; Zendah, M. Development of the brain: A vital role for cerebrospinal fluid. Can. J. Physiol Pharmacol., 2003, 81, 317-328.
44. Parada, C.; Martin, C.; Alonso, M. I.; Moro, J. A.; Bueno, D.; Gato, A. Embryonic cerebrospinal fluid collaborates with the isthmic organizer to regulate mesencephalic gene expression. J. Neurosci. Res., 2005, 82, 333-345.
45. Eicher, D. J.; Moats-Staats, B. M.; Stiles, A. D.; D'Ercole, A. J. Possible autocrine/paracrine actions of insulin-like growth factors during embryonic development: Expression and action of IGFs in undifferentiated P19 cells. Dev. Genet., 1993, 14, 194-203.
46. Lee, J. E.; Pintar, J.; Efstratiadis, A. Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. Development, 1990, 110, 151-159.
47. Cavallaro, T.; Martone, R. L.; Stylianopoulou, F.; Herbert, J. Differential expression of the insulin-like growth factor II and transthyretin genes in the developing rat choroid plexus. J. Neuropathol. Exp. Neurol., 1993, 52, 153-162.
48. Calvo, R.; Morreale de, E. G.; Escobar del, R. F.; Obregon, M. J. Maternal nonthyroidal illness and fetal thyroid hormone status, as studied in the streptozotocin-induced diabetes mellitus rat model. Endocrinology, 1997, 138, 1159-1169.
49. Rizzo, T.; Metzger, B. E.; Burns, W. J.; Burns, K. Correlations between antepartum maternal metabolism and child intelligence. N. Engl. J. Med., 1991, 325, 911-916.
50. Dickson, P. W.; Aldred, A. R.; Menting, J. G.; Marley, P. D.; Sawyer, W. H.; Schreiber, G. Thyroxine transport in choroid plexus. J. Biol. Chem., 1987, 262, 13907-13915.
51. Ferguson, R. N.; Edelhoch, H.; Saroff, H. A.; Robbins, J.; Cahnmann, H. J. Negative cooperativity in the binding of thyroxine to human serum prealbumin. Preparation of tritium-labeled 8-anilino-1-naphthalenesulfonic acid. Biochemistry, 1975, 14, 282-289.
52. Raz, A.; Shiratori, T.; Goodman, D. S. Studies on the protein-protein and protein-ligand interactions involved in retinol transport in plasma. J. Biol. Chem., 1970, 245, 1903-1912.
53. Kilby, M. D. Thyroid hormones and fetal brain development. Clin. Endocrinol. (Oxf), 2003, 59, 280-281.
54. Maden, M. Retinoid signalling in the development of the central nervous system. Nat. Rev. Neurosci., 2002, 3, 843-853.
55. Krichevsky, A. M.; King, K. S.; Donahue, C. P.; Khrapko, K.; Kosik, K. S. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA, 2003, 9, 1274-1281.
56. Kousseff, B. G. Diabetic embryopathy. Curr. Opin. Pediatr., 1999, 11, 348-352.
57. Boyd, J. M.; Malstrom, S.; Subramanian, T.; Venkatesh, L. K.; Schaeper, U.; Elangovan, B.; Sa-Eipper, C.; Chinnadurai, G. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell, 1994, 79, 341-351.
58. Pani, L.; Horal, M.; Loeken, M. R. Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: Implications for Pax-3- dependent development and tumorigenesis. Genes Dev., 2002, 16, 676-680.
59. Abraham, N. G.; Kushida, T.; McClung, J.; Weiss, M.; Quan, S.; Lafaro, R.; Darzynkiewicz, Z.; Wolin, M. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ. Res., 2003, 93, 507-514
60. Wolf, G.; Schroeder, R.; Zahner, G.; Stahl, R. A.; Shankland, S. J. High glucose-induced hypertrophy of mesangial cells requires p27(Kip1), an inhibitor of cyclin-dependent kinases. Am. J. Pathol., 2001, 158, 1091-1100.
61. Fu, J.; Tay, S. S.; Ling, E. A.; Dheen, S. T. High glucose alters the expression of genes involved in proliferation and cell-fate specification of embryonic neural stem cells. Diabetologia, 2006, 49, 1027-1038.
62. Francis, F.; Koulakoff, A.; Boucher, D.; Chafey, P.; Schaar, B.; Vinet, M. C.; Friocourt, G.; McDonnell, N.; Reiner, O.; Kahn, A.; McConnell, S. K.; Berwald-Netter, Y.; Denoulet, P.; Chelly, J. Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron, 1999, 23, 247-256.
63. Friocourt, G.; Koulakoff, A.; Chafey, P.; Boucher, D.; Fauchereau, F.; Chelly, J.; Francis, F. Doublecortin functions at the extremities of growing neuronal processes. Cereb. Cortex, 2003, 13, 620-626.
64. Koizumi, H.; Tanaka, T.; Gleeson, J. G. Doublecortin-like kinase functions with doublecortin to mediate fiber tract decussation and neuronal migration. Neuron, 2006, 49, 55-66.
65. Shu, T.; Tseng, H. C.; Sapir, T.; Stern, P.; Zhou, Y.; Sanada, K.; Fischer, A.; Coquelle, F. M.; Reiner, O.; Tsai, L. H. Doublecortin-like kinase controls neurogenesis by regulating mitotic spindles and M phase progression. Neuron, 2006, 49, 25-39.
66. Hunter, K. E.; Hatten, M. E. Radial glial cell transformation to astrocytes is bidirectional: Regulation by a diffusible factor in embryonic forebrain. Proc. Natl. Acad. Sci. U.S.A., 1995, 92, 2061-2065.
67. Malatesta, P.; Hack, M. A.; Hartfuss, E.; Kettenmann, H.; Klinkert, W.; Kirchhoff, F.; Gotz, M. Neuronal or glial progeny: Regional differences in radial glia fate. Neuron, 2003, 37, 751-764
68. Noctor, S. C.; Flint, A. C.; Weissman, T. A.; Dammerman, R. S.; Kriegstein, A. R. Neurons derived from radial glial cells establish radial units in neocortex. Nature, 2001, 409, 714-720.
69. Parnavelas, J. G.; Nadarajah, B. Radial glial cells. are they really glia? Neuron, 2001, 31, 881-884.
70. Fu, J.; Tay, S. S.; Ling, E. A.; Dheen, S. T. Aldose reductase is implicated in high glucose-induced oxidative stress in mouse embryonic neural stem cells. J. Neurochem., 2007, 103, 1654-1665.
71. Hatakeyama, J.; Bessho, Y.; Katoh, K.; Ookawara, S.; Fujioka, M.; Guillemot, F.; Kageyama, R. Hes genes regulate size, shape and histogenesis of the nervous system by control of the timing of neural stem cell differentiation. Development, 2004, 131, 5539-5550.
72. Qian, X.; Shen, Q.; Goderie, S. K.; He, W.; Capela, A.; Davis, A. A.; Temple, S. Timing of CNS cell generation: A programmed sequence of neuron and glial cell production from isolated murine cortical stem cells. Neuron, 2000, 28, 69-80.
73. Temple, S. The development of neural stem cells. Nature, 2001, 414, 112-117.
74. Leunda-Casi, A.; Genicot, G.; Donnay, I.; Pampfer, S.; De, H. R. Increased cell death in mouse blastocysts exposed to high D-glucose in vitro: Implications of an oxidative stress and alterations in glucose metabolism. Diabetologia, 2002, 45, 571-579.
75. Zanetti, M.; Zwacka, R.; Engelhardt, J.; Katusic, Z.; O'Brien, T. Superoxide anions and endothelial cell proliferation in normoglycemia and hyperglycemia. Arterioscler. Thromb. Vasc. Biol., 2001, 21, 195-200.
76. Chang, T. I.; Horal, M.; Jain, S. K.; Wang, F.; Patel, R.; Loeken, M. R. Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia, 2003, 46, 538-545.
77. Evers, I. M.; de Valk, H. W.; Visser, G. H. Risk of complications of pregnancy in women with type 1 diabetes: Nationwide prospective study in the Netherlands. BMJ, 2004, 328, 915.
78. Cleves, M. A.; Hobbs, C. A. Collaborative strategies for unraveling the complexity of birth defects. J. Matern. Fetal Neonatal Med., 2004, 15, 35-38.
79. Reece, E. A.; Hobbins, J. C. Diabetic embryopathy: Pathogenesis, prenatal diagnosis and prevention. Obstet. Gynecol. Surv., 1986, 41, 325-335.
80. Freinkel, N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes, 1980, 29, 1023-1035.
81. Cederberg, J.; Galli, J.; Luthman, H.; Eriksson, U. J. Increased mRNA levels of Mn-SOD and catalase in embryos of diabetic rats from a malformation-resistant strain. Diabetes, 2000, 49, 101-107.
82. Eriksson, U. J.; Borg, L. A. Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia, 1991, 34, 325-331.
83. Eriksson, U. J.; Borg, L. A. Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes, 1993, 42, 411-419.
84. Goldman, A. S.; Baker, L.; Piddington, R.; Marx, B.; Herold, R.; Egler, J. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc. Natl. Acad. Sci. U.S.A., 1985, 82, 8227-8231.
85. Hashimoto, M.; Akazawa, S.; Akazawa, M.; Akashi, M.; Yamamoto, H.; Maeda, Y.; Yamaguchi, Y.; Yamasaki, H.; Tahara, D.; Nakanishi, T. et al. Effects of hyperglycaemia on sorbitol and myoinositol contents of cultured embryos: Treatment with aldose reductase inhibitor and myo-inositol supplementation. Diabetologia, 1990, 33, 597-602.
86. Shum, L.; Sadler, T. W. Biochemical basis for D,L,-beta-hydroxybutyrate-induced teratogenesis. Teratology, 1990, 42, 553-563.
87. Eriksson, U. J.; Siman, C. M. Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring. Diabetes, 1996, 45, 1497-1502.
88. Siman, C. M.; Eriksson, U. J. Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia, 1997, 40, 1416-1424.
89. Horal, M.; Zhang, Z.; Stanton, R.; Virkamaki, A.; Loeken, M. R. Activation of the hexosamine pathway causes oxidative stress and abnormal embryo gene expression: Involvement in diabetic teratogenesis. Birth Defects Res. A Clin. Mol. Teratol., 2004, 70, 519-527.
90. Li, R.; Chase, M.; Jung, S. K.; Smith, P. J.; Loeken, M. R. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am. J. Physiol. Endocrinol. Metab., 2005, 289, E591-E599.
91. Yang, X.; Borg, L. A.; Eriksson, U. J. Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am. J. Physiol., 1997, 272, E173-E180.
92. Vincent, A. M.; Russell, J. W.; Low, P.; Feldman, E. L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev., 2004, 25, 612-628.
93. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001, 414, 813-820.
94. Allen, D. A.; Yaqoob, M. M.; Harwood, S. M. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J. Nutr. Biochem., 2005, 16, 705-713.
95. El-Kabbani, O.; Wilson, D. K.; Petrash, M.; Quiocho, F. A. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites. Mol. Vis., 1998, 4, 19.
96. Urzhumtsev, A.; Tete-Favier, F.; Mitschler, A.; Barbanton, J.; Barth, P.; Urzhumtseva, L.; Biellmann, J. F.; Podjarny, A.; Moras, D. A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil. Structure, 1997, 5, 601-612.
97. Costantino, L.; Rastelli, G.; Vianello, P.; Cignarella, G.; Barlocco, D. Diabetes complications and their potential prevention: Aldose reductase inhibition and other approaches. Med. Res. Rev., 1999, 19, 3-23.
98. Dunlop, M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int. Suppl., 2000, 77, S3-12.
99. Kinoshita, J. H.; Nishimura, C. The involvement of aldose reductase in diabetic complications. Diabetes Metab. Rev., 1988, 4, 323-337.
100. Yabe-Nishimura, C. Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications. Pharmacol. Rev., 1998, 50, 21-33.
101. Costantino, L.; Rastelli, G.; Cignarella, G.; Barlocco, D. Synthesis and aldose reductase inhibitory activity of a new series of benz[h]cinnolinone derivatives. Farmaco, 2000, 55, 544-552.
102. El-Kabbani, O.; Darmanin, C.; Oka, M.; Schulze-Briese, C.; Tomizaki, T.; Hazemann, I.; Mitschler, A.; Podjarny, A. High-resolution structures of human aldose reductase holoenzyme in complex with stereoisomers of the potent inhibitor Fidarestat: Stereospecific interaction between the enzyme and a cyclic imide type inhibitor. J. Med. Chem., 2004, 47, 4530-4537.
103. Klebe, G.; Kramer, O.; Sotriffer, C. Strategies for the design of inhibitors of aldose reductase, an enzyme showing pronounced induced-fit adaptations. Cell Mol. Life Sci., 2004, 61, 783-793.
104. Petrash, J. M. All in the family: Aldose reductase and closely related aldo-keto reductases. Cell Mol. Life Sci., 2004, 61, 737-749.
105. Podjarny, A.; Cachau, R. E.; Schneider, T.; Van, Z. M.; Joachimiak, A. Subatomic and atomic crystallographic studies of aldose reductase: implications for inhibitor binding. Cell Mol. Life Sci., 2004, 61, 763-773.
106. Miyamoto, S. Molecular modeling and structure-based drug discovery studies of aldose reductase inhibitors. Chem-Bio. Inform. J., 2002, 2, 74-85.
107. Li, H.; Gu, Y.; Zhang, Y.; Lucas, M. J.; Wang, Y. High glucose levels down-regulate glucose transporter expression that correlates with increased oxidative stress in placental trophoblast cells in vitro. J. Soc. Gynecol. Investig., 2004, 11, 75-81.
108. Moley, K. H.; Chi, M. M.; Mueckler, M. M. Maternal hyperglycemia alters glucose transport and utilization in mouse preimplantation embryos. Am. J. Physiol., 1998, 275, E38-E47.
109. Ogura, K.; Sakata, M.; Yamaguchi, M.; Kurachi, H.; Murata, Y. High concentration of glucose decreases glucose transporter-1 expression in mouse placenta in vitro and in vivo. J. Endocrinol., 1999, 160, 443-452.
110. Vannucci, S. J.; Maher, F.; Simpson, I. A. Glucose transporter proteins in brain: Delivery of glucose to neurons and glia. Glia, 1997, 21, 2-21.
111. Hogan, A.; Heyner, S.; Charron, M. J.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Thorens, B.; Schultz, G. A. Glucose transporter gene expression in early mouse embryos. Development, 1991, 113, 363-372.
112. Aghayan, M.; Rao, L. V.; Smith, R. M.; Jarett, L.; Charron, M. J.; Thorens, B.; Heyner, S. Developmental expression and cellular localization of glucose transporter molecules during mouse preimplantation development. Development, 1992, 115, 305-312.
113. Carayannopoulos, M. O.; Chi, M. M.; Cui, Y.; Pingsterhaus, J. M.; McKnight, R. A.; Mueckler, M.; Devaskar, S. U.; Moley, K. H. GLUT8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocyst. Proc. Natl. Acad. Sci. U.S.A., 2000, 97, 7313-7318.
114. Dan-Goor, M.; Sasson, S.; Davarashvili, A.; Almagor, M. Expression of glucose transporter and glucose uptake in human oocytes and preimplantation embryos. Hum. Reprod., 1997, 12, 2508-2510.
115. Pantaleon, M.; Harvey, M. B.; Pascoe, W. S.; James, D. E.; Kaye, P. L. Glucose transporter GLUT3: Ontogeny, targeting, and role in the mouse blastocyst. Proc. Natl. Acad. Sci. U.S.A., 1997, 94, 3795-3800.
116. Zhou, Y.; Kaye, P. L.; Pantaleon, M. Identification of the facilitative glucose transporter 12 gene Glut12 in mouse preimplantation embryos. Gene Expr. Patterns, 2004, 4, 621-631.
117. Smith, D. E.; Gridley, T. Differential screening of a PCR-generated mouse embryo cDNA library: Glucose transporters are differentially expressed in early postimplantation mouse embryos. Development, 1992, 116, 555-561.
118. Matsumoto, K.; Akazawa, S.; Ishibashi, M.; Trocino, R. A.; Matsuo, H.; Yamasaki, H.; Yamaguchi, Y.; Nagamatsu, S.; Nagataki, S. Abundant expression of GLUT1 and GLUT3 in rat embryo during the early organogenesis period. Biochem. Biophys. Res. Commun., 1995, 209, 95-102.
119. Takao, Y.; Akazawa, S.; Matsumoto, K.; Takino, H.; Akazawa, M.; Trocino, R. A.; Maeda, Y.; Okuno, S.; Kawasaki, E.; Uotani, S. et al. Glucose transporter gene expression in rat conceptus during high glucose culture. Diabetologia, 1993, 36, 696-706.
120. Trocino, R. A.; Akazawa, S.; Takino, H.; Takao, Y.; Matsumoto, K.; Maeda, Y.; Okuno, S.; Nagataki, S. Cellular-tissue localization and regulation of the GLUT-1 protein in both the embryo and the visceral yolk sac from normal and experimental diabetic rats during the early postimplantation period. Endocrinology, 1994, 134, 869-878.
121. Moley, K. H.; Chi, M. M.; Knudson, C. M.; Korsmeyer, S. J.; Mueckler, M. M. Hyperglycemia induces apoptosis in preimplantation embryos through cell death effector pathways. Nat. Med., 1998, 4, 1421-1424.
122. Vannucci, S. J.; Gibbs, E. M.; Simpson, I. A. Glucose utilization and glucose transporter proteins GLUT-1 and GLUT-3 in brains of diabetic (db/ db) mice. Am. J. Physiol., 1997, 272, E267-E274.
123. Bialik, S.; Cryns, V. L.; Drincic, A.; Miyata, S.; Wollowick, A. L.; Srinivasan, A.; Kitsis, R. N. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ. Res., 1999, 85, 403-414.
124. Chi, M. M.; Pingsterhaus, J.; Carayannopoulos, M.; Moley, K. H. Decreased glucose transporter expression triggers BAX-dependent apoptosis in the murine blastocyst. J. Biol. Chem., 2000, 275, 40252-40257.
125. Deckwerth, T. L.; Easton, R. M.; Knudson, C. M.; Korsmeyer, S. J.; Johnson, E. M., Jr. Placement of the BCL2 family member BAX in the death pathway of sympathetic neurons activated by trophic factor deprivation. Exp. Neurol., 1998, 152, 150-162.
126. Li, W.; Liu, X.; He, Z.; Yanoff, M.; Jian, B.; Ye, X. Expression of apoptosis regulatory genes by retinal pericytes after rapid glucose reduction. Invest. Ophthalmol. Vis. Sci., 1998, 39, 1535-1543.
127. Yerby, M. S. Clinical care of pregnant women with epilepsy: Neural tube defects and folic acid supplementation. Epilepsia, 2003, 44 Suppl 3, 33-40.
128. Wentzel, P.; Gareskog, M.; Eriksson, U. J. Folic acid supplementation diminishes diabetes- and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes, 2005, 54, 546-553.
129. Jia, D. Y.; Liu, H. J.; Wang, F. W.; Liu, S. M.; Ling, E. A.; Liu, K.; Hao, A. J. Folic acid supplementation affects apoptosis and differentiation of embryonic neural stem cells exposed to high glucose. Neurosci. Lett., 2008, 440, 27-31.
130. Cogram, P.; Tesh, S.; Tesh, J.; Wade, A.; Allan, G.; Greene, N. D.; Copp, A. J. D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects. Hum. Reprod., 2002, 17, 2451-2458.
131. Greene, N. D.; Copp, A. J. Inositol prevents folate-resistant neural tube defects in the mouse. Nat. Med., 1997, 3, 60-66.
132. Lumley, J.; Watson, L.; Watson, M.; Bower, C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst. Rev., 2001, CD001056.
133. Wald, N. J.; Law, M. R.; Morris, J. K.; Wald, D. S. Quantifying the effect of folic acid. Lancet, 2001, 358, 2069-2073.